Key result
Cardiac MR imaging is a valuable method for diagnosing hypertrophic cardiomyopathy, identifying phenotypes, and risk stratification through accurate measurement of wall thickness and detection of myocardial fibrosis.
Answers are grounded in this paper and cite their sources.
Cardiac MR imaging provides accurate morphological assessment and risk stratification (via LGE for fibrosis) in patients with hypertrophic cardiomyopathy.
Hypertrophic cardiomyopathy (HCM) is a relatively common myocardial genetic disease having a wide variety of symptoms and prognoses. The most serious complications of HCM are sudden cardiac death induced by ventricular arrhythmia or inappropriate changes in blood pressure, and heart failure. Cardiac MR imaging is a valuable imaging method for detecting HCM because of its accurate measurement of wall thickness and myocardial mass without limited view and the unique ability of late gadolinium enhancement (LGE) to identify myocardial fibrosis related to the prognosis of HCM. Tagging and T1 or T2 mapping MR imaging techniques have emerged as quantitative methods for the evaluation of disease severity. In this review, we introduce the MR imaging techniques applied to HCM and demonstrate the typical phenotypes and some morphological characteristics of HCM. In addition, we discuss the clinical relevance of MR imaging for risk stratification and management of HCM.
No takes yet. Share an insight, caveat, or question.
Amano et al. (2018) conducted a review in Hypertrophic cardiomyopathy (HCM). Cardiac MR Imaging was evaluated. Cardiac MR imaging is a valuable method for diagnosing hypertrophic cardiomyopathy, identifying phenotypes, and risk stratification through accurate measurement of wall thickness and detection of myocardial fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: